Regional GMP Network Leverage Eurofins BioPharma Product Testing Germany’s position within the world’s largest GMP testing network and Europe-wide presence to cross-sell full batch release, method development/validation, stability studies, and in vitro toxicology services to pharma and biotech customers seeking compliant, end-to-end testing.

Regulatory Excellence Highlight GMP and GLP certifications, ISO 17025 for medical devices, and multiple FDA audits to reassure potential clients about quality and compliance, creating opportunities for new audits, site expansions, or additional validated testing services.

Diversified Capabilities Position the lab as a one-stop partner for raw materials, APIs, finished drugs, small and large molecules, and biologics with cross-audit access across the BPT network to support customers with scale-up, variety of assays, and accelerated timelines.

Strategic Partnerships capitalize on historical acquisitions and collaborations within Eurofins network (Cosmetics & Personal Care, DNA sequencing, UgenTec collaboration) to target customers seeking integrated bio-analytical, genomic, and toxicology solutions alongside traditional GMP testing.

Geographic Growth Emphasize Europe-wide location footprint (over 30 sites) and recent expansions in related Eurofins entities (e.g., soil testing via FarmFacts) to propose geographic scalability, site-specific expertise, and capacity support for regional launches or multinational programs.